STOCK TITAN

[SCHEDULE 13G] Aptevo Therapeutics Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BIGGER CAPITAL FUND L P
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Date:06/25/2025
Bigger Capital Fund GP, LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:06/25/2025
Bigger Michael
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger
Date:06/25/2025
Exhibit Information

99.1 - Joint Filing Agreement

Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

APVO Latest News

APVO Latest SEC Filings

APVO Stock Data

3.17M
738.10k
0.01%
4.85%
4.12%
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE